Artificial intelligence (AI) is transforming noninvasive cancer diagnostics by enabling earlier, more accurate detection through advanced data analytics and imaging. In oncology, AI analyzes large datasets from genomics, pathology, and radiology to understand cancer progression. Combined with high-resolution imaging and next-generation sequencing, it improves diagnosis, prediction, and personalized treatment. AI also identifies new biomarkers and targeted therapies, helping reduce mortality and enhance patient outcomes.
The report includes:
- Impact analysis of artificial intelligence (AI) on the global noninvasive cancer diagnostics market
- Case studies for successful integration of AI, particularly machine learning (ML) and deep learning (DL) algorithms for early detection and diagnosis of cancer
- Review of AI’s role in cancer care and treatment, including enhanced diagnosis, personalized treatment, clinical decision support, biomarker discovery and drug development
- Insights of current trends of AI adoption in modern cancer diagnostics across major geographic regions
- Understanding of the market disruptions across the industry verticals and AI impact on various stages of value chain
- A competitive landscape featuring strategic initiatives, market spendings and VC funding outlook
Table of Contents
Chapter 1 Key Use Cases for AI Adoption in Noninvasive Cancer Diagnostics Technologies
Chapter 2 AI Adoption Trends
Chapter 3 AI Disruption Trends
Chapter 4 Market Spending and Investment Scenario
Chapter 5 Abbreviations
List of Tables
List of Figures
